|
09.00 – 10.30
|
SESSION 1
|
|
09.00
|
THE ABCD Debate
This house believes that the current NICE guidelines are out of date, lack patient
focus and are not fit for purpose.
Professor Miles Fisher, Glasgow & Dr Amanda Adler, Cambridge
|
|
10.30
|
Tea, coffee and posters.
|
|
11.00 – 12.30
|
SESSION 2
|
|
11.00
|
Quantifying a case for change: How IMPACT 2 justifies improved glycaemic control as a health care priority.
Dr Mike Baxter, Sanofi
|
|
11.30
|
Symposium sponsored by NovoNordisk Ltd
Chaired by Professor Steve Bain, Swansea
Cardiovascular outcomes in Type 2 diabetes
Background to CVOT’s
Professor John Petrie, Glasgow
Recent CVOT findings
Professor Steve Bain, Swansea
Discussion and Q & A
|
|
12.30 – 13.15
|
Lunch and posters.
|
|
13.15 – 15.00
|
SESSION 3
|
|
13.15
|
The 4th Niru Goenka Lecture
Diabetes Care For You: Re-inventing Diabetes Care in Brighton & Hove
Dr. Paul Grant, Sussex Community Foundation NHS Trust
|
|
14.15
|
T1DM in Athletes
Roddy Riddle (runner) and Chris Pennell (rugby).
|
|
15.00
|
Tea, coffee and posters.
|
|
15.15 – 16.30
|
SESSION 4
|
|
15.15
|
Current worksforce
Dr Stella George, East & North Herts NHS Trust
|
|
15.30
|
Time for diabetologists to measure their hormone: utility and interpretation of C peptide in T1DM.
Professor Andrew Hattersley, Exeter
|
|
16.00
|
Iodine levels in mothers and infants and the impact on brain development.
Dr Fiona Williams, Dundee
|
|
16.30
|
SpR presentations, the best to receive the “ABCD Best Research Travel Grant”
Estimating the potential risk reduction of Type 2 diabetes mellitus (T2DM) complications if systolic blood pressure (SBP) targets were to be lowered
Dr Samiul Mostafa, DTU, Oxford University
Does glycaemic control improve in adults with Type 1 diabetes after attending CarbAware, a novel, 3 hour, structured education course?
Dr Gaya Thanabalasingham, Royal Berkshire NHS Foundation Trust.
|
|
17.00
|
Meeting closes.
|
|
